Physician
General Surgery
Dr. Jonathan B. Mitchem, MD
|
|
Give Review
Jonathan Mitchem works in the field of General Surgery. He studied medicine at The Ohio State University College of Medicine. Jonathan Mitchem is a published doctor. He has 14 publications published. The most current publication "Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer."
Publications
- Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.
- A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: a Role for Targeting the CCL2/CCR2 Axis.
- Targeting tumor-infiltrating macrophages decreases tumor-Initiating cells, relieves immunosuppression and improves chemotherapeutic response.
- Endoscopic and robotic thyroidectomy for cancer.
- Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.
- Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure.
- A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: Management and outcomes.
- Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.
- Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy.
- Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
- Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer.
- The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.
Schools
Ohio State University College of Medicine
Doctors Specialties
- General Surgery
Accepted Insurances
Education
-
Washington University -
The Ohio State University College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Jacqueline M. Saito, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sekhar Dharmarajan, MD |
|
|
Dr. Theodore J. Dubuque Jr., MD |
|
|
Dr. Julian C. Mosley Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Blanke, MD |
|
|
Dr. Mark F. Blumenthal, MD |
|
|
Dr. Hudson B. Binnington Jr., MD |
|
|
Dr. John A. Gorski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Darren R. Cullinan, MD |
|
|
Dr. Alexander Lin, MD |
|
|
Dr. Jacob R. Hopping, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfredo I. Custodio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley M. Holder, MD |
|
|
Dr. Tara Skebba, MD |
|
|
Dr. Joshua D. Sommovilla, MD
This Doctor is OpenDoctor Recommended.
|